Metropolis Healthcare Limited

Price Chart

Risk-Adjusted Performance

Metropolis Healthcare Limited (METROPOLIS) Price Performance

Metropolis Healthcare Limited (METROPOLIS) trades on NSE in INR. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at INR471.70, down 0.12% from the previous close.

Over the past year, METROPOLIS has traded between a low of INR421.75 and a high of INR2235.37. The stock has lost 76.4% over this period. It is currently 78.9% below its 52-week high.

Metropolis Healthcare Limited has a market capitalization of $98.01B, with a price-to-earnings ratio of 58.51.

About Metropolis Healthcare Limited

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinical trial research, hospital lab management, and home collection services, as well as profiles, blood tests, and soft radiology services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, youth, and corporates. In addition, the company develops and deals in technology driven products and services. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, a mobile app, a website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.